| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. (AUPH) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. AUPH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 13.04M | $214.71M | +814.6K | |
| CEO | 1.85M | $30.37M | - | |
| COO | 695.8K | $11.45M | - | |
| CFO | 626.4K | $10.31M | - | |
| VP | 557.4K | $9.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Martin Michael Robert82 | Chief Business Officer | Sale+OE | 150,000 | $30.25 | $4,537,280.00 | -27.6% | -34.5% | -81.7% | |
| Nov 11, 2021 | Solomons Neil82 | Chief Medical Officer | Sale+OE | 250,000 | $30.03 | $7,508,300.00 | -41.0% | -34.5% | -81.7% | |
| Nov 1, 2021 | Solomons Neil82 | Chief Medical Officer | Sale+OE | 45,000 | $31.64 | $1,423,800.00 | -24.7% | -48.9% | -75.5% | |
| Nov 1, 2021 | Martin Michael Robert82 | Chief Business Officer | Sale+OE | 45,000 | $31.64 | $1,423,800.00 | -20.3% | -48.9% | -75.5% | |
| Oct 25, 2021 | Huizinga Robert Bindert77 | EVP Of Research | Sale+OE | 130,000 | $29.75 | $3,867,500.00 | -66.4% | -47.3% | -75.2% | |
| Sep 21, 2021 | Huizinga Robert Bindert77 | EVP Of Research | Sale+OE | 32,500 | $23.99 | $779,533.04 | -13.6% | -7.0% | -67.0% | |
| Sep 21, 2021 | Martin Michael Robert82 | Chief Business Officer | Sale+OE | 116,000 | $23.44 | $2,718,725.00 | -17.5% | -7.0% | -67.0% | |
| Sep 14, 2021 | Martin Michael Robert82 | Chief Business Officer | Sale+OE | 44,000 | $21.78 | $958,220.00 | -10.3% | -7.4% | -65.2% | |
| Sep 14, 2021 | Huizinga Robert Bindert77 | EVP Of Research | Sell | 32,500 | $21.15 | $687,325.00 | -8.1% | -7.4% | -65.2% | |
| Sep 14, 2021 | Martin Michael Robert82 | Chief Business Officer | Sale+OE | 115,000 | $20.89 | $2,402,217.00 | -24.5% | -7.4% | -65.2% |